RECQL and glioblastoma: Because RECQ1 was found to be overexpressed in glioblastomas, we next investigated the sensitivity of glioblastoma cells to temozolomide (TMZ), which is an anticancer alkylating agent commonly used for the treatment of human brain tumors.